Z.A. Khan et al. / Tetrahedron 66 (2010) 6639–6646
6645
0.65 g) in dry ethanol (30 mL) at 0 ꢀC. The reaction mixture was
stirred for 16 h at rt. The reaction was cooled to 0 ꢀC and aq HCl
(1 M, 15 mL) was added carefully. The reaction mixture was
extracted with diethyl ether (3ꢁ20 mL). The combined organic
phases were washed with brine, dried with Na2SO4 and evaporated
under reduced pressure. The crude product was purified by flash
chromatography (ethyl acetate/hexane 1:10) and the product (E/Z
1:2.1) was obtained in 97% yield (2.95 mmol, 0.62 g) as colourless
oil.
were washed with brine (3ꢁ5 mL), dried with Na2SO4 and con-
centrated under reduced pressure. The crude was purified by flash
chromatography (ethyl acetate/hexane 1:10). The title compound
4a0 was obtained as a mixture with compound 4a (2:1) in 46%
overall yield (0.082 mmol, 25 mg).
1H NMR (500 MHz, CDCl3):
d
¼6.80 (2H, m, Ar–H), 5.64 (1H, d,
J¼5.0 Hz), 4.64 (1H, d, J¼5.0 Hz), 3.88 (3H, s, –COOCH3) ppm; 13C
NMR (125 MHz, CDCl3):
d
¼80.6, 56.0, 53.3, 49.8, 29.0 ppm. Other
signals are merged with compound 4a. IR (n): 3034, 2953, 2851,
(Z)-Isomer: 1H NMR (500 MHz, CDCl3):
Ar–CH]CH–Ph); 6.58 (1H, d, J¼12.2 Hz, Ar–CH]CH–Ph), 4.55 (2H,
s, –CH2OH) ppm; 13C NMR (125 MHz, CDCl3):
¼63.5 (CH2OH) ppm;
): 3381, 3064,
d¼6.65 (1H, d, J¼12.2 Hz,
1781, 1735, 1559, 1436, 1282, 1229, 1154, 1110 cmꢂ1; HRMS: [MþH]þ
calcd for C19H17O4: 309.1121; found: 309.1126.
d
Other signals of (E)- and (Z)-isomers are merged. IR (
n
3.34. Calculations
3021, 2920, 2851, 1597, 1559, 1443, 1040 cmꢂ1. HRMS: [MꢂH]þ calcd
for C15H13O: 209.0972; found: 209.0970.
Ab initio calculations were performed by using Gaussian 03
program (revision B.04).35 Geometries were fully optimized at
B3LYP/6-31G(d) level, and the obtained energy minimum struc-
tures were characterized by frequency calculation at the same
calculation level. The energies were corrected with zero-point
energies. The NMR chemical shifts were calculated at B3LYP/6-
31G(d) level by the Gauge-Independent Atomic Orbital (GIAO)
method36 using an NMR keyword.
3.31. (E)-and (Z)-Dimethyl 2-(2-styrylbenzyl)malonate
The title compound was prepared according to GP3 starting
from (E)- and (Z)-isomer of the corresponding alcohol (2.76 mmol,
0.58 g) in 28% yield (0.77 mmol, 0.25 g) as a colourless oil.
(Z)-Isomer: 1H NMR (500 MHz, CDCl3):
d
¼6.73 (1H, d, J¼12.2 Hz,
Ar–CH]CH–Ph); 6.69 (1H, d, J¼12.2 Hz, Ar–CH]CH–Ph), 3.70 (6H,
s, COOCH3), 3.28 (2H, d, J¼8.0 Hz, CH2) ppm; 13C NMR (125 MHz,
Acknowledgements
CDCl3):
d
¼32.82 (–CH2OH), 52.5 (OCH3), 52.6 (CH[COOMe]2), 169.3
(C]O) ppm. Other signals of (E)- and (Z)-isomers signals are
We thank the Higher Education Commission, Pakistan, for
support, the EPSRC National Mass Spectrometry Service Centre,
Swansea, for mass spectrometric data and Dr. B. Kariuki, Cardiff
University, for the X-ray analysis of 4a.
merged. IR (n): 3060, 3024, 2952, 2847, 1754, 1735, 1495, 1436, 1276,
1229, 1151 cmꢂ1; HRMS: [MþH]þ calcd for C20H21O4: 325.1434;
found: 325.1441.
3.32. Procedure for the synthesis of dimethyl 2-2(2-(3-
phenyloxiran-2-yl)benzyl)malonate (6)
Supplementary data
Supplementary data associated with this article can be found in
To a solution of compound 3a (1.26 mmol, 428 mg) in chloro-
form (20 mL) mCPBA (1.89 mmol, 423 mg) was added. The reaction
mixture was stirred at rt for 16 h. To the reaction mixture aq satd
NaHCO3 (2ꢁ15 mL) was added and extracted with diethyl ether
(3ꢁ20 mL). The combined organic phases were washed with brine,
dried with Na2SO4, evaporated under reduced pressure and sub-
jected to column chromatography (ethyl acetate/hexane 1:20). The
title compound was obtained in 95% yield (1.20 mmol, 410 mg) as
colourless oil.
References and notes
1. (a) Inoue, T.; Kitagawa, O.; Saito, A.; Taguchi, T. J. Org. Chem. 1997, 62, 7384; (b)
Inoue, T.; Kitagawa, O.; Oda, Y.; Taguchi, T. J. Org. Chem. 1996, 61, 8256; (c)
Kitagawa, O.; Inoue, T.; Hirano, K.; Taguchi, T. J. Org. Chem. 1993, 58, 3106; (d)
Barluenga, J.; Palomas, D.; Rubio, E.; Gonzalez, J. M. Org. Lett. 2007, 9, 2823; (e)
Siegel, D. R.; Danishefsky, S. J. J. Am. Chem. Soc. 2006, 128, 1048.
2. (a) Kunstmann, R.; Lerch, U.; Gerhards, H.; Leven, M.; Schacht, U. J. Med. Chem.
1984, 27, 432; (b) Smith, A. B.; Charnley, A. K.; Harada, H.; Beiger, J. J.; Cantin, L.-D.;
Kenesky, C. S.; Hirschmann, R.; Munshi, S.; Olsen, D. B.; Stahlhut, M. W.; Schleif,
W. A.; Kuo, L. C. Bioorg. Med. Chem. Lett. 2006, 16, 859; (c) Misra, R.; Pandey, R. C.;
Silverton, J. V. J. Am. Chem. Soc.1982,104, 4478; (d) Akai, S.; Tsujino, T.; Fukuda, N.;
Iio, K.; Takeda, Y.; Kawaguchi, K.; Naka, T.; Higuchi, K.; Akiyama, E.; Fujioka, H.;
Kita, Y. Chem.dEur. J. 2005,11, 6286; (e) Saxena, D. B. Phytochem.1986, 25, 553; (f)
Pass, M.; Bolton, R. E.; Coote, S. J.; Finch, H.; Hindley, S.; Lowdon, A.; McDonald, E.;
McLaren, J.; Owen, M.; Pegg, N. A.; Mooney, C. J.; Tang, C.-M.; Parry, S.; Patel, C.
Bioorg. Med. Chem. Lett. 1999, 9, 431.
3. (a) Cimetiere, B.; Dubuffet, T.; Landras, C.; Descombes, J.-J.; Simonet, S.; Ver-
beuren, T. J.; Lavielle, G. Bioorg. Med. Chem. Lett. 1998, 8, 1381; (b) Stutz, A.;
Georgopoulos, A.; Granitzer, W.; Petranyi, G.; Berney, D. J. Med. Chem. 1986, 29,
112; (c) Dumas, M.; Dumas, J.-P.; Bardou, M.; Rochette, L.; Advenier, C.; Giu-
dicelli, J.-F. Eur. J. Pharmacol. 1998, 348, 223.
4. (a) Akiyama, K.; Matsuzaki, K.-I.; Hayashi, H. Nature 2005, 435, 824; (b) Umehara,
M.; Hanada, A.; Yoshida, S.; Akiyama, K.; Arite, T.; Takeda-Kamiya, N.; Magome,
H.; Kamiya, Y.; Shirasu, K.; Yoneyama, K.; Kyozuka, J.; Yamaguchi, S. Nature 2008,
455, 195; (c) Gomez-Roldan, V.; Fermas, S.; Brewer, P. B.; Puech-Pages, V.; Dun, E.
A.; Pillot, J.-P.; Letisse, F.; Matusova, R.; Danoun, S.; Portais, J.-C.; Bouwmeester, H.;
Becard, G.; Beveridge, C. A.; Rameau, C.; Rochange, S. F. Nature 2008, 455,189; (d)
Schachtschabel, D.; Boland, W. ChemBioChem 2009, 10, 221.
1H NMR (500 MHz, CDCl3):
d¼7.42–7.36 (5H, m, Ar–H), 7.32–
7.26 (3H, m, Ar–H), 7.21 (1H, d, J¼7.4 Hz), 4.10 (1H, d, J¼1.9 Hz), 3.80
(1H, d, J¼2.0 Hz), 3.69 (1H, t, J¼7.3 Hz), 3.64 (3H, s, COOMe), 3.60
(3H, s, COOMe), 3.32 (2H, d, J¼7.2 Hz) ppm; 13C NMR (125 MHz,
CDCl3):
d
¼169.1, 169.0, 136.8, 135.8, 135.5, 129.5, 128.6, 128.4, 128.0,
127.5, 125.6, 124.7, 62.2, 60.4, 52.59, 52.55, 31.4 ppm; IR (n): 3070,
3033, 2953, 2847, 1754, 1734, 1575, 1491, 1456, 1435, 1282, 1232,
1153 cmꢂ1; HRMS: [MþNH4]þ calcd for C20H24O5N: 358.1649;
found: 358.1652.
3.33. (3S,3aS,8aR)-Methyl 1-oxo-phenyl-3,3a,8,8a-tetrahydro-
1H-indeno[2,1-c]furan-8a-carboxylate (4a0)
tBuOK (0.36 mmol, 40 mg) was added to a solution of epoxide 6
(0.18 mmol, 61 mg) in t-BuOH (3 mL). The reaction mixture was
stirred for 6 h. The reaction mixture was quenched with aq 1 M HCl
(2ꢁ5 mL) and extracted with ethyl acetate (3ꢁ5 mL). The combined
organic phases were washed with brine (3ꢁ5 mL), dried with
Na2SO4 and evaporated under reduced pressure. The crude product
was dissolved in MeOH (6 mL) and treated with a catalytic amount
of concd H2SO4 in the presence of molecular sieves (4 Å). The
reaction mixture was stirred at rt for 24 h. The reaction mixture was
filtered. The filtrate was quenched with water (10 mL) and extrac-
ted with ethyl acetate (3ꢁ10 mL). The combined organic phases
5. (a) Palmer, M. J.; Kenny, J. A.; Walsgrove, T.; Kawamoto, A. M.; Wills, M. J. Chem.
Soc., Perkin Trans. 1 2002, 416; (b) Rodrı´guez-Escrich, S.; Sola`, L.; Jimeno, C.;
Rodrı´guez-Escrich, C.; Perica`s, M. A. Adv. Synth. Catal. 2008, 350, 2250.
6. Gao, H.; Angelici, R. J. J. Am. Chem. Soc. 1997, 119, 6937.
7. Kurteva, V. B.; Santos, A. G.; Afonso, C. A. M. Org. Biomol. Chem. 2004, 2, 514.
8. Kropp, P. J.; Breton, G. W.; Craig, S. L.; Crawford, S. D.; Durland, W. F.; Jones, J. E.;
Raleigh, J. S. J. Org. Chem. 1995, 60, 4146.
9. Grise, C. M.; Barriault, L. Org. Lett. 2006, 8, 5905.
10. Nishiyama, Y.; Hamanaka, S.; Ogawa, A.; Kambe, N.; Sonoda, N. J. Org. Chem.
1988, 53, 1326.